Dyne Therapeutics director Dirk Kersten disposes of 261,460 common shares worth $6.67 million
DYN•Director reports share sales
Dyne Therapeutics director Dirk Kersten reported sales of 261,460 common shares on July 27.
Shares sold at weighted-average prices of $25.5 and $26.04.
Indirect beneficial ownership fell to 3,586,796 shares following the transactions.
